Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
Carmine Zoccali(Università Campus Bio-Medico), Rainer H. Böger(Universität Hamburg), Ignazio Bellanuova(University of Catania), Francesca Mallamaci(Metabolism and Renal Physiology), Isabella Fermo(Vita-Salute San Raffaele University), Alessandro Cataliotti(University of Catania), Stefanie M. Bode‐Böger(Medizinische Hochschule Hannover), Frank Benedetto(Metabolism and Renal Physiology), Lorenzo Malatino(University of Catania), Jürgen C. Frölich, Giovanni Tripepi(Metabolism and Renal Physiology)
Cited by 1,092
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808